Oramed Pharmaceuticals
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	8/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$2.70M N/A	$2.70M 0%	$1.34M -50.42%	Avg: $2M Low: $2M High: $2M avg. 49.25%	Avg: $2.99M Low: $2.99M High: $2.99M avg. 49.72%	Avg: $3.07M Low: $3.07M High: $3.07M avg. 2.59%
Net Income % change YoY	$-22.23M N/A	$-37.76M -69.81%	$5.52M 114.63%	Avg: $-14.5M Low: $-14.03M High: $-11.69M avg. -362.44%	Avg: $-49.13M Low: $-49.13M High: $-49.13M avg. -238.87%	Avg: $-31.97M Low: $-31.97M High: $-31.97M avg. 34.92%
EBITDA % change YoY	$-25.03M N/A	$-36.97M -47.67%	$-15.57M 57.88%	Avg: $-2M Low: $-2M High: $-2M avg. 87.15%	Avg: $-2.99M Low: $-2.99M High: $-2.99M avg. -49.72%	Avg: $-3.07M Low: $-3.07M High: $-3.07M avg. -2.59%
EPS % change YoY	-$0.78 N/A	-$0.97 -24.35%	$0.14 114.43%	Avg: -$0.33 Low: -$0.36 High: -$0.3 avg. -335.71%	Avg: -$1.26 Low: -$1.26 High: -$1.26 avg. -281.81%	Avg: -$0.82 Low: -$0.82 High: -$0.82 avg. 34.92%
Operating Expenses % change YoY	$26.92M N/A	$43.30M 60.81%	$17.10M -60.48%	Avg: $5.03M Low: $5.03M High: $5.03M avg. -70.54%	Avg: $7.54M Low: $7.54M High: $7.54M avg. 49.72%	Avg: $7.73M Low: $7.73M High: $7.73M avg. 2.59%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -188.79% in 2025-2027.

We have gathered data from 2 analysts. Their low estimate is -14.03M, average is -14.5M and high is -11.69M.

Wall Street analysts forecast annual average revenue growth of 33.85% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $2M, average is $2M and high is $2M.

Wall Street analysts forecast annual average earnings growth of -194.20% in 2025-2027.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.36, average is -$0.33 and high is $-0.3.